New device catches debris during heart valve procedure to protect the brain

NCT ID NCT07627984

Completed Disease control Sponsor: Shanghai Shenqi Medical Technology Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a device designed to catch and remove debris that can break loose during transcatheter aortic valve replacement (TAVR), a procedure to replace a narrowed heart valve. The device uses two filters placed in arteries leading to the brain. The trial involved 260 people and measured brain lesions on MRI scans after the procedure. The goal was to see if the device reduces brain injury and improves safety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cerebral embolic protection device
What this could lead to: If it works, this device could make TAVR safer by reducing the risk of brain damage from debris during the procedure.
What could go wrong: This is a completed trial with 260 participants, but the device only protects certain brain areas and may not prevent all complications. It is not a treatment for the underlying heart disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic valve stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CEREBRAL EMBOLICPROTECTION DEVICE TAVR

Contacts and locations

Locations

Xiamen Cardiovascular Hospital Xiamen University

Xiamen, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.